表紙
市場調查報告書

益生菌·補充品的全球市場:市場佔有率·規模·趨勢分析與未來預測 (2018∼2026年)

Probiotics Dietary Supplements Market Share, Size, Trends, & Industry Analysis Report, By Application (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula), By Regions, Segment Forecast, 2018 - 2026

出版商 Polaris Market Research 商品編碼 873289
出版日期 內容資訊 英文 110 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
益生菌·補充品的全球市場:市場佔有率·規模·趨勢分析與未來預測 (2018∼2026年) Probiotics Dietary Supplements Market Share, Size, Trends, & Industry Analysis Report, By Application (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula), By Regions, Segment Forecast, 2018 - 2026
出版日期: 2019年03月01日內容資訊: 英文 110 Pages
簡介

本報告提供全球益生菌系的營養補充品的市場相關分析,彙整產品的特性和市場基本結構,主要的推動及阻礙市場要素,產業的向心力,整體市場規模趨勢預測 (今後8年份),各用途·各地區的詳細趨勢,主要企業的簡介等資訊,為您概述為以下內容。

第1章 分析的概要與範圍

第2章 摘要整理

第3章 益生菌·補充品市場分析

  • 益生菌·補充品:產業概況
  • 益生菌·補充品市場價值鏈·通路分析
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素/課題分析
    • 市場機會分析
  • 產業分析:波特的五力分析
  • 益生菌·補充品市場:PEST分析
  • 益生菌·補充品產業趨勢
  • 企業排行榜分析

第4章 益生菌·補充品市場:市場規模與其預測,各用途

  • 分析概要
  • 營養補充品
  • 營養供給劑
  • 特殊營養成分
  • 嬰幼兒配方奶粉
  • 其他

第5章 益生菌·補充品市場:市場規模與其預測,各地區

  • 分析概要
  • 北美 (美國,加拿大)
  • 歐洲 (德國,英國,法國,義大利)
  • 亞太地區 (中國,印度,日本,澳洲)
  • 南美 (巴西,墨西哥)
  • 中東·非洲

第6章 企業簡介

  • BioGaia AB
    • 概要
    • 財務指標
    • 產品的互相比較
    • 近幾年趨勢
  • NutraScience Labs
  • Winclove Probiotics BV
  • Probi AB
  • Nutraceutix
  • AB Biotics
  • Probiotical SpA
  • ProbioFerm
  • Lallemand
  • Protexin
目錄
Product Code: PM1591

The global probiotics dietary supplements market size is anticipated to reach USD 7.10 billion by 2026 growing at a CAGR of 7.8% from 2018 to 2026 according to a new report published by Polaris Market Research. The report 'Probiotics Dietary Supplements Market Share, Size, Trends, & Industry Analysis Report, [By Application (Food Supplements, Nutritional Supplements, Specialty Nutrients, Infant Formula), By Regions]: Segment Forecast, 2018 - 2026' provides insights on the current market scenario and the future prospects.

Probiotics are live bacteria's that facilitates digestive functioning in human body. Most of the bacteria are considered under probiotic but in specific terminology Lactobacillus is commonly found across fermented food and beverages. The common application of probiotics in human includes treatment of certain conditions such as Irritable bowel syndrome, Inflammatory bowel disease, and diarrhea caused by antibiotics.

Rising awareness about consumer wellbeing through health care, expanding research and development funding for developing cutting edge probiotics products, and growing interest from developed countries are fueling the market growth. Likewise, high item proliferation is influencing the market growth. On the other hand, stringent regulations, low consumer awareness are hindering the market.

The demand for preventive medicines businesses is on the ascent, because of the high number of baby boomers experiencing digestive related afflictions, the higher enthusiasm of middle-aged grown-ups in maintaining digestive health, alongside the absence of balanced dietary intakes. The benefits of probiotics for other health conditions, such as sports nutrition, immunity, and women's health, among many others are becoming increasingly common as clinical research continues to introduce the ways in which the strains of bacteria strengthen health.

Rising obesity rates in US and shifting emphasis on weight management solutions, with solid spotlight on satiety, calorie-consuming, and fat-burning ingredients properties. The growing demand for weight management is one of the key factors positively impacting the probiotic dietary supplements market.

As per the national Digestive Diseases Information Clearinghouse (NDDIC), over 70 million people in the U.S. suffer from digestive diseases and an additional 50 million suffer from chronic constipation. Such rapidly including heath concerns has resulted in increased consumption of probiotics dietary supplements.

Asia Pacific and Africa, being the biggest future markets for probiotics dietary supplements where lack of consumer awareness and need for various health and wellness measures are among the prime objectives that requires immediate attention. Environmental factors play significant role in production of probiotics, as microorganisms are highly sensitive to our altering environment.

Government controls, investment in research & development, and rising awareness for healthy lifestyles are the components that are relied upon to enhance probiotics demand in the next few years. anticipated to drive industry growth over the forecast period. Brazil, China and India are among the promising marketspaces in this sector.

Some of the key players profiled in the global probiotic dietary supplements market: BioGaia AB (Sweden), Winclove Probiotics BV (the Netherlands), Probi AB (Sweden), AB Biotics, SA (Spain), Probiotical SpA (Italy), Super Smart Holdings Limited (Hong Kong) and Protexin (U.K).

Polaris Market Research has segmented the global probiotic dietary supplements market on the basis of Application and Region:

Probiotic Dietary Supplements Application Outlook (Revenue, USD Million, 2015 - 2026)

  • Food Supplements
  • Nutritional Supplements
  • Specialty Nutrients
  • Infant Formula
  • Others

Probiotic Dietary Supplements Region Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa

Table of Contents

1. Overview and Scope

  • 1.1. Research goal & scope
  • 1.2. Research assumptions
  • 1.3. Research Methodology
    • 1.3.1. Primary data sources
    • 1.3.2. Secondary data sources
  • 1.4. Key take-away
  • 1.5. Stakeholders

2. Executive Summary

  • 2.1. Market Definition
  • 2.2. Market Segmentation

3. Probiotics Dietary Supplements Market Insights

  • 3.1. Probiotics dietary supplements industry snapshot
  • 3.2. Probiotics dietary supplements value chain & distribution analysis
  • 3.3. Probiotics dietary supplements market dynamics
    • 3.3.1. Probiotics dietary supplements Market driver analysis
    • 3.3.2. Probiotics dietary supplements Market restraint/challenges analysis
    • 3.3.3. Probiotics dietary supplements Market opportunity analysis
  • 3.4. Industry analysis - Porter's five force
  • 3.5. Probiotics dietary supplements market PEST analysis, 2017
  • 3.6. Probiotics dietary supplements industry trends
  • 3.7. Competitive company ranking analysis

4. Probiotics Dietary Supplements Market Size and Forecast, By Application

  • 4.1. Key Findings
  • 4.2. Food Supplements
  • 4.3. Nutritional Supplements
  • 4.4. Specialty Nutrients
  • 4.5. Infant Formula
  • 4.6. Others

5. Probiotics Dietary Supplements Market Size and Forecast by Regions

  • 5.1. Key findings
  • 5.2. North America
    • 5.2.1. U.S.
    • 5.2.2. Canada
  • 5.3. Europe
    • 5.3.1. UK
    • 5.3.2. Germany
    • 5.3.3. France
    • 5.3.4. Italy
  • 5.4. Asia Pacific
    • 5.4.1. China
    • 5.4.2. India
    • 5.4.3. Japan
    • 5.4.4. Australia
  • 5.5. Latin America
    • 5.5.1. Brazil
    • 5.5.2. Mexico
  • 5.6. Middle East & Africa

6. Company Profiles

  • 6.1. BioGaia AB
    • 6.1.1. Overview
    • 6.1.2. Financials
    • 6.1.3. Product Benchmarking
    • 6.1.4. Recent Developments
  • 6.2. NutraScience Labs
    • 6.2.1. Overview
    • 6.2.2. Financials
    • 6.2.3. Product Benchmarking
    • 6.2.4. Recent Developments
  • 6.3. Winclove Probiotics BV
    • 6.3.1. Overview
    • 6.3.2. Financials
    • 6.3.3. Product Benchmarking
    • 6.3.4. Recent Developments
  • 6.4. Probi AB
    • 6.4.1. Overview
    • 6.4.2. Financials
    • 6.4.3. Product Benchmarking
    • 6.4.4. Recent Developments
  • 6.5. Nutraceutix
    • 6.5.1. Overview
    • 6.5.2. Financials
    • 6.5.3. Product Benchmarking
    • 6.5.4. Recent Developments
  • 6.6. AB Biotics
    • 6.6.1. Overview
    • 6.6.2. Financials
    • 6.6.3. Product Benchmarking
    • 6.6.4. Recent Developments
  • 6.7. Probiotical SpA
    • 6.7.1. Overview
    • 6.7.2. Financials
    • 6.7.3. Product Benchmarking
    • 6.7.4. Recent Developments
  • 6.8. ProbioFerm
    • 6.8.1. Overview
    • 6.8.2. Financials
    • 6.8.3. Product Benchmarking
    • 6.8.4. Recent Developments
  • 6.9. Lallemand
    • 6.9.1. Overview
    • 6.9.2. Financials
    • 6.9.3. Product Benchmarking
    • 6.9.4. Recent Developments
  • 6.10. Protexin
    • 6.10.1. Overview
    • 6.10.2. Financials
    • 6.10.3. Product Benchmarking
    • 6.10.4. Recent Developments
Back to Top